NCT02174861 A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention. Status COMPLETED Phase PHASE2
NCT02170337 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps Status COMPLETED Phase PHASE1
NCT02157948 A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis Status COMPLETED Phase PHASE3
NCT02147951 Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma Status NO_LONGER_AVAILABLE Phase N/A
NCT02138838 Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis Status TERMINATED Phase PHASE3
NCT02137343 A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancer Status TERMINATED Phase PHASE3
NCT02132429 Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects Status TERMINATED Phase PHASE1
NCT02129699 Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy Status TERMINATED Phase PHASE3
NCT02128230 UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission Status TERMINATED Phase PHASE2
NCT02126449 DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT02125344 A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) Status COMPLETED Phase PHASE3
NCT02114931 Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT02103283 A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE1
NCT02102204 Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis Status COMPLETED Phase PHASE3
NCT02101164 Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease Status WITHDRAWN Phase PHASE4
NCT02099461 Effect of Denosumab on Cellular Biomarkers in the Human Breast Status COMPLETED Phase PHASE1
NCT02096666 A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects Status COMPLETED Phase PHASE1/PHASE2
NCT02087943 Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2